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OBJECTIVES: To investigate the relative importance of common physical and mental disorders with regard to
the number of days out-of-role (DOR; number of days for which a person is completely unable to work or carry
out normal activities because of health problems) in a population-based sample of adults in the Sa ˜o Paulo
Metropolitan Area, Brazil.
METHODS: The Sa ˜o Paulo Megacity Mental Health Survey was administered during face-to-face interviews with
2,942 adult household residents. The presence of 8 chronic physical disorders and 3 classes of mental disorders
(mood, anxiety, and substance use disorders) was assessed for the previous year along with the number of days
in the previous month for which each respondent was completely unable to work or carry out normal daily
activities due to health problems. Using multiple regression analysis, we examined the associations of the
disorders and their comorbidities with the number of days out-of-role while controlling for socio-demographic
variables. Both individual-level and population-level associations were assessed.
RESULTS: A total of 13.1% of the respondents reported 1 or more days out-of-role in the previous month, with
an annual median of 41.4 days out-of-role. The disorders considered in this study accounted for 71.7% of all
DOR; the disorders that caused the greatest number of DOR at the individual-level were digestive (22.6), mood
(19.9), substance use (15.0), chronic pain (16.5), and anxiety (14.0) disorders. The disorders associated with the
highest population-attributable DOR were chronic pain (35.2%), mood (16.5%), and anxiety (15.0%) disorders.
CONCLUSIONS: Because pain, anxiety, and mood disorders have high effects at both the individual and societal
levels, targeted interventions to reduce the impairments associated with these disorders have the highest
potential to reduce the societal burdens of chronic illness in the Sa ˜o Paulo Metropolitan Area.
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& INTRODUCTION
Similar to many low- and middle- income countries (1),
Brazil is facing an epidemiologic transition (2) characterized
by an increasing burden of chronic, non-communicable
diseases surpassing infectious diseases (3). According to the
most recent Global Burden of Diseases (GBD) report (4,5), 8
of the 10 leading causes of years living with disability (YLD)
in the Tropical Latin America region are either chronic pain
or mental disorders. The results from the first GBD report in
Brazil (2) showed that neuropsychiatric disorders ranked
first as the major cause of YLD (34%), followed by chronic
respiratory diseases (11.2%).
The World Health Organization (WHO) International
Classification of Functioning, Disability and Health (6)
defines disability as a broad term for impairments, activity
limitations, and participation restrictions, taking into
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1392account the interaction between health problems and
personal and environmental factors. The number of work-
days lost is an important component of disabilities, which
can be measured by the number of missed days of work
(absenteeism) and low performance while at work (pre-
senteeism) (7). In this report, we focus on the number of
days out-of-role (DOR), which was defined as the number of
days in the 30 days before the interview for which the
person was completely unable to work or carry out normal
activities because of health problems.
Examining the effects of health problems on the DOR in
the 24 countries that participated in the World Mental
Health (WMH) Surveys, Alonso and colleagues (8) found
that neurological disorders, mood disorders, and anxiety
disorders were the most powerful predictors of the DOR at
the individual-level, and chronic pain had the greatest
population-level effect. This data pattern was quite con-
sistent across countries with different income levels. In
Brazil, information on the DOR is scarce and most previous
studies were based on administrative official workers’
compensation databases obtained from the Brazilian
National Social Security Institute (INSS) (9-11). Such data
are limited because the Brazilian labor laws require that
people miss 15 days of work (absenteeism) before they are
entitled to request compensation benefits (sick leave), which
means that the much more commonly occurring cases of
absence due to sickness with fewer than 15 DOR are
omitted. Five of the 10 leading causes of Social Security
compensation benefit requests are mental disorders, which
are responsible for 19% of the total costs associated with
disability benefits (9). In a population-based study, Yano
and Santana (12) reported a 1-year prevalence of workdays
lost due to health problems of 12.5%, 5.5% of which was
directly related to disorders and 4.1% of which was related
to disorders aggravated by work. However, no information
was provided on the illnesses associated with the DOR. It is
essential to quantify the relative importance of specific
disorders in accounting for the DOR and to evaluate the
extent to which preventive interventions at multiple levels
can reduce the impact of the disorders associated with the
largest losses. Achieving these goals requires epidemiologi-
cal data on a broad range of disorders, with adjustments for
the high rates of comorbidity within and between physical
and mental disorders (8,13-16).
The current report presents such relevant data from the
Sa ˜o Paulo Megacity Mental Health Survey (SPMHS), which
is the Brazilian component of the WHO’s WMH Survey
Initiative (www.hcp.med.harvard.edu/wmh). Located in
Southeastern Brazil, the Sa ˜o Paulo Metropolitan Area
(SPMA) houses more than 10% of the Brazilian population
(17) and is the fifth largest metropolitan area in the world,
with approximately 20 million inhabitants. Thus, the SPMA
is an important industrial and commercial center in the
Latin American and Caribbean region. The WMH Survey
Initiative was launched to carry out general population
surveys in countries throughout the world to assess the
prevalence and associations with mental disorders (18). One
section in the WMH interview assesses the presence of
commonly occurring chronic physical disorders, which
allows for comparison of the effects of mental and physical
disorders on role functioning. In a previous study (19), we
found that 1 in every 3 adults living in SPMA had a 12-
month history of a mental disorder and that 10% of
the respondents had a ‘severe’ mental disorder, which
represents more than one million adults. These results
suggest that mental disorders are likely to have a significant
impact on the ability of an individual to perform work
activities. In addition, in this previous study, we found
comorbidities associated with mental disorders to be a
common occurrence, with most of the morbidities concen-
trated in approximately 40% of the active cases that
presented with 2 or more disorders. In the current study,
we aimed to directly quantify the relative importance of
mental and physical disorders on the DOR in a 12-month
period, adjusting for the effects of comorbidity.
& METHODS
Sample
The SPMHS was designed to be a representative sample
survey of household residents aged 18 years and older in
the SPMA, an area that consists of the state capital city of
Sa ˜o Paulo and its 38 surrounding municipalities, covering a
geographical area of 8,051 km
2 (20). At the time of data
collection (May 2005 to May 2007), 11 million inhabitants
were 18 years or older (20). A detailed description of the
sampling and weighting methods is presented elsewhere
(21). Briefly, respondents were selected using a stratified,
multistage area probability sample of households. Within
each household, 1 respondent per household was selected
through a Kish table. In all strata, the primary sampling
units (PSUs) were 2,000 cartographically defined census
count areas (20). Each municipality contributed to the total
sample size according to its population size.
Initially, 7,700 households were selected to achieve the
planned sample of 5,000 subjects, allowing for a 35% non-
response rate. Eligible respondents were those who were 18
years or older, Portuguese-speaking household residents,
and without any disability or handicap that would other-
wise impair their ability to participate in the interview. A
total of 5,237 subjects agreed to participate, but 200 elderly
respondents were considered ineligible due to cognitive
impairment. The sample size, after sampling, recruitment,
and obtaining informed consent, was 5,037. The overall
survey response rate was 81.3%.
All interviews were administered face-to-face by trained
lay interviewers using training and field quality control
procedures as previously described (18,22,23). Each inter-
view consisted of 2 parts. Part I, which was administered to
all respondents, contained assessments of core mental
disorders (mood, anxiety, impulse-control, and substance
use disorders, as well as suicidal behavior). All Part I
respondents who met the criteria for any core mental
disorder plus a probability sub-sample of Part I non-case
respondents were administered Part II, which assessed
correlates and additional anxiety disorders, such as obses-
sive-compulsive disorders (OCDs) and post-traumatic stress
disorders (PTSDs). Thus, Part II was divided into 2 strata
based on the Part I responses. The first stratum was
composed of 2,236 subjects (44.4%) who met the lifetime
criteria for at least 1 of the mental disorders assessed in Part
I. The second stratum consisted of a random 25% sub-
sample of non-cases associated with WMH-CIDI Part I
disorders, with a total of 706 (14.0%) respondents. The
inclusion of this stratum enabled the comparison of cases
and non-cases and correlates of psychiatric morbidity, as
well as allowed assessment of additional diagnoses among
respondents who were negative for core disorders. Data
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1393were weighted to adjust for the under-sampling of Part II
non-cases and to adjust for residual discrepancies between
the sample and population distributions of a range of socio-
demographic variables. The total number of Part II
respondents was 2,942, and these respondents are the focus
of the current report.
Ethics statement
The Research and Ethics Committee of the University of
Sa ˜o Paulo Medical School approved the procedures of the
SPMHS for recruitment, obtainment of informed consent,
and protection of human subjects during the field studies.
Respondents were interviewed only after signing an
informed written consent form and had assurance of total
confidentiality.
Measurement
Mental disorders. Mental disorders were assessed with
version 3.0 of the WHO Composite International Diagnostic
Interview (CIDI), a fully structured, lay-administered
interview designed to generate research diagnoses of
common mental disorders according to the definitions and
criteria of both the DSM-IV and ICD-10 diagnostic systems
(24). The mental disorders considered here include mood
disorders (major depressive disorder and bipolar disorder),
anxiety disorders (panic disorder and/or agoraphobia,
specific phobia, social phobia, generalized anxiety
disorder, and post-traumatic stress disorder), and
substance use disorders (SUDs: alcohol abuse with and
without dependence and drug abuse with and without
dependence). Only the disorders present in the 12 months
prior to the interview are considered here.
Blind clinical re-interviews using the Structured Clinical
Interview for DSM-IV Axis I disorder (SCID-I) (25) with a
probability sub-sample of WMH respondents showed
generally good agreement between the WMH-CIDI and
SCID diagnoses (26). Preliminary results of the clinical
reappraisal study in the SPMHS with a probability sub-
sample of 775 respondents (not included in the previous
validation study cited above) showed good total classifica-
tion accuracy (range: 76-99%) and an area under the receiver
operating characteristic curve of approximately 0.7 for any
disorder.
Chronic physical disorders. Physical disorders were
assessed with a standard chronic disorders checklist.
Checklists of this type have been shown to yield more
complete and accurate reports of disorder prevalence than
estimates derived from responses to open-ended questions
(27,28). Reports based on such checklists have been shown
in previous methodological studies to have moderate to
good concordance with medical records (29,30).
The 8 disorders considered here are arthritis, cardiovas-
cular disorders (heart attack, heart disease, hypertension,
and stroke), chronic pain disorders (chronic back or neck
pain and other chronic pain), diabetes, migraines or other
frequent or severe headaches, insomnia, digestive disorders
(stomach or intestinal ulcers), and respiratory disorders
(seasonal allergies, asthma, COPD, and emphysema). The
symptom-based disorders in this set (arthritis, pain dis-
orders, heart attack, and stroke) were assessed based on the
respondents’ reports as to whether they experienced the
disorder in the 12 months prior to the interview, while the
remaining disorders were assessed based on respondent
reports of whether a doctor or other health professional had
ever told them they had the disorder, and only the disorders
that had been present in the previous year were considered.
Days out-of-role. A modified version (31) of the WHO
Disability Assessment Schedule (WHO-DAS) (32) was used
to ask respondents the number of days in the 30 days before
the interview (i.e., beginning yesterday and going back 30
days) for which they were completely unable to work or
carry out their normal activities because of problems with
either physical health, mental health, or the use of alcohol or
drugs. The recall period for the DOR (30 days) was different
from the period for disorders (12 months) because we
wanted to include effects not only of active disorders but
also of recent disorders that may still have important effects
on the participants’ health valuations. Good concordance of
these reports has been documented between payroll records
of employed people (33,34) and prospective daily diary
reports (35).
Statistical analysis
Multiple regression analysis was performed to examine
associations of the physical and mental disorders assessed
in the survey with the reported DOR in the past 30 days,
controlling for age, gender, employment status, and educa-
tion. As substantial comorbidity was found among the
disorders (36), models were estimated that captured the
effects of comorbidity. However, because there are 1,556
(2
11- 12) logically possible interactions among the 11
disorders, some constraints had to be imposed on the
interaction models. Although a number of constrained
models were estimated, the best-fitting model was a model
that included a single composite estimate of the interaction
between each of the 11 disorders and the weighted sum of
the other 10 disorders, where the weights used to calculate
the sum were the regression coefficients associated with the
marginal effects of the other 10 disorders under the model
with the outcome. The term ‘marginal effect’ is used to
describe the effect of a given disorder among respondents
who have 1 and only 1 disorder, i.e., a comparison of the
DOR among respondents who have either a single focal
disorder or who have none of the disorders outside of the
control variables. Iterative nonlinear regression analysis was
used to estimate the coefficients in this model (37), with the
inclusion of a separate dummy predictor variable for each of
the 11 disorders, a weighted count of all the disorders
experienced by respondents who had 2 or more disorders
(coded 0 for respondents with either 0 or 1 disorder), and a
term for the interaction between each of the 11 disorder-
specific dummy predictor variables and the weighted sum.
This model was estimated iteratively using the regression
coefficients from the previous iteration of the model to
calculate the weighted sum and then continuing to calculate
successively revised weighted sums in each new iteration
until the solution converged. The regression coefficients in
this final model associated with the 11 disorder-specific
dummy variables can be interpreted as marginal effects of
the disorders, while the coefficients associated with the
interactions can be interpreted as the extent to which the
incremental effect of the focal disorder varies as a function
of comorbidity magnitude. A SAS macro (40) was written to
implement this procedure.
Because the outcome variable (a 0-30 measure of the
number of days out-of-role) was highly skewed, the use of
ordinary least squares regression analysis to estimate the
above model is likely to yield estimates that are both biased
Days out-of-role due to common disorders
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1394and inefficient (37). We addressed this problem using
generalized linear models (GLMs) in SAS (40) to investigate
a range of nonlinear link functions and non-normal
error structures to build a better-fitting model. Standard
diagnostic procedures to compare the model fit (38) showed
that the GLM with a log link function and variance
proportional to the mean was the best-fitting model. The
results reported below are based on this model.
As the prediction equation includes interaction terms, the
predictive effect of each disorder is impossible to determine
by inspection of the model coefficients. This problem was
addressed by performing simulations to produce a single
term that summarized all of the component interaction
effects of each disorder. The simulation was performed by
estimating the predicted value of the outcome for each
respondent based on the coefficients in the final model (the
base estimate) and then repeating this exercise in a modified
form 11 different times, each time assuming that 1 of the 11
disorders no longer existed (i.e., by recalculating each
individual’s weighted sum based on the assumption that
the focal disorder was not present and then multiplying out
predicted values on the outcome using the final model
coefficients based on the assumption that the individual did
not have the focal disorder and assuming that the weighted
sum was equal to its value in the absence of the focal
disorder). The estimated individual-level effect of each
disorder was obtained by subtracting the predicted value of
the outcome in the restricted version of the model (i.e., the
version of the model that deleted the focal disorder is not
considered) from the value in the unrestricted version and
calculating the mean differences in the subsample of
respondents who did, in fact, have the focal disorder. The
estimated societal-level effect of the disorder was then
obtained by multiplying the individual-level estimate by the
prevalence of the disorder to calculate the mean DOR due to
the disorder and then by dividing that product by the total
mean DOR to produce an expression of the proportion of all
DOR in the population due to the focal disorder. The same
procedure was used to calculate the societal-level effects of
any physical disorder, any mental disorder, and any of the
11 considered disorders. A SAS macro (40) was written to
implement these simulations.
Because the SPMHS data are geographically clustered and
weighted, design-based methods were needed to obtain
accurate estimates of standard errors and statistical sig-
nificance. The Taylor series linearization method (39)
implemented in SAS (40) was used for this purpose in the
basic model. The more computationally intensive method of
Jackknife Repeated Replications (39), implemented in a SAS
macro that we wrote for this purpose, was used to obtain
standard errors of the simulated estimates of individual-
level and societal-level disorder effects. Significance tests
were consistently evaluated using 0.05-level, two-sided
design-based tests.
& RESULTS
Of the 2,942 respondents, 52.8% (SE 1.4) were female,
40.2% (SE 1.6) were not married, the mean age was 39.0
years (SE 0.5), 45.0% (SE 1.5) had at least 8 years of
education, and 20.6% (SE 1.0) were not working (retired or
unemployed) at the time of data collection (Table 1).
The distribution of the days out-of-role
The mean number of health-related DOR in the previous
month was 1.3 in the total sample (Table 2), representing an
annualized median of 15.8 (SE 2.0). The overall mean can be
decomposed into 13.1% (SE 1.3) of respondents who reported
any DOR, among whom the mean DOR was 9.9, representing
an annualized median of 120.1 (SE 7.4) DOR. The median
among those with any DOR was 3.4 days, with a right-
skewed distribution, which was lower than the mean,
representing an annualized median of 41.4 (SE 5.5) DOR.
Disorder prevalence estimates
Three-fourths (73.5%) of the respondents reported 1 or
more of the disorders included in this study (Table 3). The
proportion of respondents reporting at least 1 physical
disorder during the previous 12 months (68.5%) was more
than 2-fold higher than the proportion reporting any mental
disorder during the previous 12 months (27.3%).
Chronic pain disorders were the most commonly reported
physical disorders (33.5%), followed by headaches/
migraines (29.2%), respiratory disorders (24.6%), cardiovas-
cular disorders (22.0%), and insomnia (12.1%). Anxiety
disorders were the most common mental disorders (17.0%),
followed by mood disorders (13.1%).
The mean DOR per year varied by disorder (Table 3).
Respondents with any disorder had an average of 20 more
DOR in a year than those without disorders. The top 7
disorders associated with the highest mean number of DOR
were digestive disorder (53.0), arthritis (39.0), mood
disorder (38.8), substance use disorder (35.6), anxiety
disorder (33.7), chronic pain disorder (30.6), and diabetes
Table 1 - Demographic characteristics of the Sa ˜o Paulo
Megacity Mental Health Survey sample (n=2,942).
Unweighted Weighted
N % SE N % SE
Gender
Women 1703 57.9 0.9 1554 52.8 1.4
Men 1239 42.1 0.9 1388 47.2 1.4
Age (years)
18-24 407 13.8 0.7 583.3 19.8 1.2
25-34 684 23.2 0.7 719.3 24.4 1.2
35-49 1028 34.9 0.7 959.7 32.6 1.3
50-64 594 20.2 0.7 445.2 15.1 0.9
65 or + 229 7.8 0.5 234.5 7.9 0.7
Education
Low (0-4 years) 799 27.2 0.7 668.7 22.7 1.0
Medium-low (5-8 years) 733 24.9 0.7 655.1 22.3 1.0
Medium-high (9-11 years) 976 33.2 0.9 1064.0 36.2 1.3
High (12 or more years) 434 14.7 0.6 554.3 18.8 1.2
Income
Low 730 24.8 0.8 644.0 21.9 0.9
Medium-low 818 27.8 0.7 838.2 28.5 0.9
Medium-high 673 22.9 0.8 661.5 22.5 1.0
High 721 24.5 0.8 798.3 27.1 1.2
Marital Status
Married 1848 62.8 1.0 1759.0 59.8 1.5
Previously Married 592 20.1 0.6 480.6 16.3 1.0
Never Married 502 17.1 0.7 702.5 23.9 1.1
Occupation
Working/student 1767 60.1 0.9 1948.0 66.2 1.2
Work at home 494 16.8 0.7 387.9 13.2 0.7
Retired 279 9.5 0.5 249.4 8.5 0.5
Unemployed 402 13.7 0.6 356.8 12.1 0.9
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more DOR (30.1) than those with any physical disorder
(19.8).
Comorbidity was the norm; specifically, respondents who
reported any disorder had an average of 2.8 disorders, and
71.5% of respondents with a disorder reported at least 2
disorders. The odds ratios (ORs) between the pairs of
disorders were largely positive (92.7% of all the 11610/
2=55 ORs between the pairs of disorders) and statistically
significant (74.5% of all ORs). The ORs were higher (median
and inter-quartile range) among pairs of physical (2.2, 1.7-
2.6) and mental (2.4, 1.9-3.9) disorders than between
physical-mental pairs (1.5, 1.2-2.6) (detailed results of all
ORs are available upon request).
Effects of disorders on the DOR
Although the 11 interaction terms in the iterative non-
additive GLM model were significant as a set in predicting
the DOR (x
2
11=65.3, p,0.001), the only individually sig-
nificant interaction term was for anxiety disorders. This
interaction term was negative, which means that the impact
of anxiety disorders on the DOR becomes smaller as the
number of comorbid disorders increases. The marginal effect
of anxiety disorders, in comparison, was significantly
positive, which means that pure anxiety is associated with
an elevated number of DOR. The negative interaction means
that the magnitude of this elevation decreases as comorbidity
increases. However, as noted in the section on analysis
methods, the magnitudes of the coefficients in the
GLM equation are difficult to interpret both because the
coefficients are expressed in terms of a log link function and
because the presence of composite interaction terms makes it
impossible to identify the total effects of any single disorder.
The simulation method described in the section on analysis
methods was used to transform these coefficients into a more
easily interpretable form.
Table 4 shows the individual- and societal-level effects of
each disorder on the DOR in a way that combines the
marginal effects of pure disorders and incremental effects of
comorbid disorders (Table 4).
Focusing first on the individual-level effects, our results
show that 4 of the 11 disorders, namely pain, anxiety, mood,
and substance disorders, are significant. Individual-level
effects are quite similar across the 4 disorders, which are
associated with a range of 14.0-19.9 DOR per year. However,
due to the much higher prevalence of pain disorders than
either anxiety or mood disorders and the much higher
prevalence of anxiety and mood disorders than substance
use disorders, the societal-level effect of pain disorders
(35.2% of all DOR) is much greater than the societal-level
effects of anxiety (15.0%) or mood (16.5%) disorders, while
the latter effects are much higher than the societal-level
effect of substance use disorders (3.6%). Taken together, the
physical disorders account for a higher proportion of all
Table 2 - Distribution of the number of days completely out of role in the month prior to the interview among the total
population and among respondents with a positive number of days out of role. Data were obtained from the Sa ˜o Paulo
Megacity Mental Health Survey (n=2,942).
Total population Respondents with non-zero days out of role
0 days, % (SE) 86.9 (1.3) 0.0
1 day, % (SE) 2.6 (0.4) 20.0 (3.2)
2 days, % (SE) 2.2 (0.5) 16.6 (2.7)
3-5 days, % (SE) 2.7 (0.4) 20.6 (2.6)
6-10 days, % (SE) 1.6 (0.3) 12.0 (1.5)
11-20 days, % (SE) 1.5 (0.3) 11.3 (1.8)
21-30 days, % (SE) 2.6 (0.4) 19.5 (2.5)
Mean, last 30 days (SE) 1.3 (0.2) 9.9 (0.6)
Median, last 30 days (SE) 0.0 (0.2) 3.4 (0.5)
Mean, annual (SE) 15.8 (2.0) 120.1 (7.4)
Median, annual (SE) 0.0 (3.0) 41.4 (5.5)
Table 3 - Twelve-month prevalence of the disorders investigated and the mean number of days completely out-of-role
per year. The Sa ˜o Paulo Megacity Mental Health Survey (n=2,942).
Disorder present in the previous 12
months Prevalence (%) SE Mean yearly DOR SE
Any physical disorder 68.5 2.0 19.8 2.4
Arthritis 7.6 0.9 39.0 9.8
Cardiovascular 22.0 1.2 24.4 2.8
Chronic pain 33.5 1.4 30.6 4.4
Diabetes 5.4 0.6 30.0 5.3
Digestive 2.6 0.2 53.0 14.3
Headache-migraine 29.2 1.5 20.9 2.8
Insomnia 12.1 0.9 26.5 3.5
Respiratory 24.6 1.1 18.2 2.2
Any mental disorder 27.3 0.8 30.1 3.7
Any mood disorder 13.1 0.7 38.8 5.6
Any anxiety disorder 17.0 0.7 33.7 5.4
Any substance disorder 3.8 0.4 35.6 8.0
Any disorder 73.5 1.7 20.0 2.4
DOR: days out-of-role.
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1396DOR (47.0%) than the mental disorders (33.5%), while all 11
disorders considered here account for 71.7% of all DOR
reported in the sample.
& DISCUSSION
We were able to directly quantify the relative importance
of mental and physical disorders in accounting for the DOR
in a population-based sample of the largest metropolitan
area in South America, where information on health-related
disability is limited.
Our results confirmed that chronic, non-communicable
diseases are highly prevalent in the general population and
cause a large amount of disability, measured as the DOR in
this Brazilian metropolitan area (2,3). Although the propor-
tion of respondents with physical illnesses was more than 2-
fold the proportion of those with mental disorders, sufferers
of common mental disorders reported approximately 50%
more DOR than those with physical disorders, showing that
mental disorders are associated with a greater amount of
productivity loss than the chronic physical disorders
assessed herein. Among physical disorders, chronic pain is
the most important contributor to the DOR, which remains
the case at the individual level, even after adjusting for
comorbidity. Our results are also in line with the recently
published GBD data for the Tropical Latin America region
(Brazil and Paraguay), which show an increasing trend in
disability levels due to common mental disorders, such as
major depression, anxiety, and SUD, as well as pain and
other musculoskeletal disorders, as the top 10 leading
causes of years living with disability (YLD) (4,5).
While respiratory and cardiovascular diseases were
highly prevalent, these disorders accounted for only a small
number of additional DOR, even when comorbidity was
considered, both at the individual and societal levels. These
results are consistent with GBD data in Brazil (2), which
reveal that cardiovascular diseases are the single most
important cause of mortality (with a contribution to years of
life lost [YLL] of 24%). However, these disorders were
responsible for 2.7% of the YLD.
At the societal level, the 11 health disorders considered in
our study accounted for more than three-quarters of all
DOR in the general population (PARP=71.7%). Physical
and mental disorders accounted for 47.0 and 33.5% of all
DOR, respectively. Our results show that chronic pain was
both highly prevalent and disabling, and it was, by far, the
most important contributor to days completely out-of-role
in the population, followed by mood and anxiety disorders.
Apart from chronic pain, arthritis and digestive diseases
were also significant physical disorders. Pain disorders and
gastrointestinal complaints have been described as some of
the most frequent somatic symptoms among the attendees
of specialty clinics and are particularly likely to remain
unexplained (41), resulting in increasing disability and a
higher utilization of health care, which is commonly
unsatisfactory (42). The self-perceived health disability of
digestive diseases was the highest among all disorders
considered herein at the individual level, dropping to fifth
in the rank at the societal level due to the low prevalence of
these disorders.
In Brazil, population-based estimates of the impact of
mental disorders at both the individual and societal levels in
terms of work loss are lacking. Mood and anxiety disorders
were highly associated with DOR in our sample and were
responsible for approximately one-third of the DOR at the
societal level. These findings are broadly consistent with
previous studies in Brazil (43), and other countries
(15,16,44,45) have revealed that mental disorders are among
the disorders most strongly associated with productivity
loss. In addition, disability benefits due to mental disorders
had a steady growth between 1998 and 2002, and depression
was the leading cause of disability benefits among indivi-
duals with mental disorders (9). Among the investigated
diseases, the prevalence of SUD in SPMHS was one of the
lowest (3.8%), but SUD contributed substantially to more
than 1 month of DOR. After controlling for comorbidities,
SUD remained strongly associated with work loss in
different aspects; it was the third most disabling cause at
the individual level, accounting for 15.0 additional yearly
DOR, and, at the population level, it exerted a significant
impact on work loss. This result is in contrast with previous
reports from other countries (8,15), which did not show such
a strong association of SUD with DOR after adjusting for
comorbidity. Nevertheless, there is considerable evidence
that SUD produces significant loss of life and disability
worldwide; for instance, the global burden of disease
attributable to alcohol and illicit drug use amounts to 5.4%
of the total burden (46,47). Therefore, our results reinforce
the finding that SUDs are an important target for improving
productivity in Brazil (48,49).
This study has a number of noteworthy limitations. First,
only a restricted set of the most common disorders was
included in the analysis, and some disorders were pooled to
form larger disorder groups. Some burdensome disorders,
such as dementia and psychosis, were not assessed in our
survey. Neurological disorders (epilepsy, multiple sclerosis,
and stroke), which have been reported as a major cause of
high individual-level effects (2,8,50), were not considered in
the analysis due to their low prevalence in our sample.
While the disorders we did include are among those most
commonly reported in previous population studies, the
expansion and disaggregation of these disorders are clearly
needed in future studies. Second, diagnoses of chronic
physical disorders were based on self-reports; however,
Table 4 - Simulated annual effects of each disorder on the
number of days completely out-of-role at the individual
1
and societal levels. Data are from the Sa ˜o Paulo Megacity
Mental Health Survey (n=2,942).
Disorder Individual level Societal level
Mean SE % SE
Any physical disorder 47.0* 12.2
Arthritis 13.7 8.4 6.6 4.0
Cardiovascular 0.0 4.9 0.0 7.1
Chronic pain 16.5* 3.7 35.2* 6.6
Diabetes 4.7 6.6 1.6 2.3
Digestive 22.6 15.0 3.7 2.3
Headache-migraine 2.1 2.9 3.9 5.5
Insomnia -1.3 3.9 -1.0 3.0
Respiratory 0.3 3.3 0.5 5.3
Any mental disorder 33.5* 7.4
Anxiety disorder 14.0* 5.4 15.0* 5.2
Mood disorder 19.9* 5.7 16.5* 4.5
Substance use disorder 15.0* 7.0 3.6* 1.8
Any disorder 71.7 4.6
*Significant at the 0.05 level, two-sided test.
1Adjusted by age, gender, education, employment, and number and type
of comorbid disorders.
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dence between self-reported chronic disorders, such as
diabetes, heart disease, and asthma, and general practitioner
records. Third, we only considered the DOR for which the
respondents reported they were completely unable to
perform their work or usual activities. It is common that
individuals also perform their role activities less or worse
than expected (e.g., presenteeism); therefore, information
about DOR underestimates total productivity loss (51).
Fourth, the target population was restricted to people living
in a large metropolitan area; generalization of the results to
individuals living in rural areas or small cities is not
warranted, even though an estimated 85% of the Brazilian
population live in urban areas (52). Finally, to increase the
validity of self-reporting, we assessed the restriction of
activities in the 30 days prior to the interview and then
extrapolated this information to the entire year, thus improv-
ing the comparability with published literature.
Implications
The results of the current report indicate that chronic pain
and mental disorders are major contributors to loss of
productivity and human capital in the adult population
living in the largest metropolitan area in Brazil. This finding
has relevant implications for the prevention of disability;
specifically, addressing only 1 disorder (either through
treatment or prevention) when it coexists with other
disorders will render a less effective outcome than addres-
sing all of the coexisting disorders. Additionally, human
resource professionals and occupational doctors who
manage prevention should make early diagnoses and
promote rehabilitation of work-related musculoskeletal pain
disorders and mental disorders.
Lowering the impact of common and disabling disorders
such as chronic pain, mood, and anxiety would have a
major productivity return. Medically unexplained symp-
toms are related to more disabling physical disorders, such
as digestive disorders and chronic pain. These disorders
should be addressed with psychosocial interventions to
avoid high spending on health services. If we take into
account the fact that indirect costs are usually higher than
direct medical and social service costs to treat disorders, the
prevention and treatment of these disorders should be cost-
effective.
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